EyeWorld Weekly, May 1, 2026
Comments Off on EyeWorld Weekly, May 1, 2026
May 1, 2026
Browse EyeWorld Weekly ophthalmology news on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
EyeWorld Weekly, April 24, 2026
➤ Topline results from Phase 2/3 study for uveal melanoma treatment ➤ Study evaluates spatial computing in cataract surgery with Apple Vision Pro ➤ Updates in DME treatment trials ➤ Company news ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, April 24, 2026
April 24, 2026
EyeWorld Weekly, April 17, 2026
➤ 36-month results from first-in-human study with shape-changing IOL ➤ New data for recently approved EDOF IOL ➤ Company completes first-in-human robotic cataract surgery ➤ Phase 2 study approved for secondary IOL intended for low-vision patients ➤ Investigational device measures real-time intraoperative aqueous outflow ➤ FDA expands dosing on label for faricimab ➤ Company news ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, April 17, 2026
April 17, 2026
EyeWorld Weekly, April 10, 2026
➤ Keep up with ASCRS Annual Meeting coverage with EyeWorld Onsite ➤ Positive topline results from Phase 3 trial for TED drug with new delivery method ➤ FDA expands dosing interval for wet AMD, DME treatment ➤ IDE granted to noninvasive bioelectric stimulation therapy for dry AMD ➤ First patients dosed in Phase 3 corneal cell therapy ➤ TED investigational treatment fails to meet primary endpoint ➤ OTC eye drop recall after FDA enforcement report cites sterility concerns ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, April 10, 2026
April 10, 2026
EyeWorld Weekly, April 3, 2026
➤ Positive topline data from Phase 3 study for thyroid eye disease treatment ➤ Controlled U.S. release of outflow restoration platform for glaucoma ➤ New platform established to help bring supportive evidence to interventional glaucoma ➤ Head-to-head Phase 1b study supports investigational anti-VEGF ➤ Complimentary access to video journal ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, April 3, 2026
April 3, 2026
EyeWorld Weekly, March 27, 2026
➤ 24-month pivotal data support efficacy of laser treatment for glaucoma ➤ Low-dose atropine drop meets primary, secondary endpoints in new data analysis ➤ Phase 2 topline data for modifier gene therapy for geographic atrophy ➤ Phase 2 data from study evaluating neuropathic corneal pain shows quality of life improvement ➤ New shelf-stable corneal endothelial cell therapy program begins ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, March 27, 2026
March 27, 2026
EyeWorld Weekly, March 20, 2026
➤ FDA issues another response letter for dry eye NDA ➤ FDA denies approval for LHON NDA ➤ Commercial launch of epithelium-on crosslinking in the U.S. ➤ Company news ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, March 20, 2026
March 20, 2026
EyeWorld Weekly, March 13, 2026
➤ FDA approves new EDOF with limited dysphotopsias ➤ Phase 1/2 12-month data for IOL-based drug delivery system ➤ Topline results from Phase 2a wet AMD study ➤ FDA grants Breakthrough Device Designation to brain implant technology ➤ FDA allows Phase 1/2 trial to begin for investigational cell therapy for familial drusen ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, March 13, 2026
March 13, 2026
EyeWorld Weekly, March 6, 2026
➤ First patients dosed in Phase 3 program evaluating sustained drug delivery for DME ➤ FDA accepts supplemental NDA for presbyopia treatment ➤ FDA grants IND to ocular inflammation, pain treatment for potential expanded indication ➤ Enrollment complete in Phase 3 trial evaluating retinitis pigmentosa therapy ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, March 6, 2026
March 6, 2026
EyeWorld Weekly, February 27, 2026
➤ First patient treated with novel crosslinking approach for refractive error ➤ Multisociety working group established to set guidelines for modern IOL classification ➤ FDA reduces clinical trial requirement for new drugs to one pivotal trial ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, February 27, 2026
February 27, 2026
- 1
- 2
- 3
- 4
- …
- 26
- Go to the next page
